Urology
Volume 71, Issue 3 , Pages 399-403 , March 2008

Saturation Prostate Biopsy in High Risk Patients After Multiple Previous Negative Biopsies

  • Kobi Stav

      Affiliations

    • Department of Urology, Assaf Harofeh Medical Center affiliated with Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Dan Leibovici

      Affiliations

    • Department of Urology, Assaf Harofeh Medical Center affiliated with Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Judith Sandbank

      Affiliations

    • Department of Pathology, Assaf Harofeh Medical Center affiliated with Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Arie Lindner

      Affiliations

    • Department of Urology, Assaf Harofeh Medical Center affiliated with Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • ,
  • Amnon Zisman

      Affiliations

    • Department of Urology, Assaf Harofeh Medical Center affiliated with Sackler Faculty of Medicine, Tel Aviv University, Zerifin, Israel
    • Corresponding Author InformationReprint requests: Amnon Zisman, M.D., Department of Urology, Assaf Harofeh Medical Center, Zerifin 70300, Israel.

Received 13 August 2007 ,Accepted 2 November 2007.

References 

  1. Norberg M, Egevad L, Holmberg L, et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562–566
  2. Levine MA, Ittman M, Melamed J, et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159:471–475
  3. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate-specific antigen values. J Urol. 1994;151:1571–1574
  4. Djavan B, Ravery V, Zlotta A, et al. Prospective evaluation of prostate cancer detected on biopsies 1, 2, 3 and 4: when should we stop?. J Urol. 2001;166:1679–1683
  5. Catalona WH, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J Urol. 1994;151:1283–1290
  6. Cooner WH, Mosley BR, Rutherford CL, et al. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990;143:1146–1154
  7. Jones JS, Oder M, Zippe CD. Saturation prostate biopsy with periprostatic block can be performed in office. J Urol. 2002;168:2108–2110
  8. Stewart CS, Leibovich BC, Weaver AL, et al. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol. 2001;166:86–91
  9. Fleshner N, Klotz L. Role of saturation biopsy in the detection of prostate cancer among difficult diagnostic cases. Urology. 2002;60:93–97
  10. Walz J, Graefen M, Chun FK, et al. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series. Eur Urol. 2006;50:498–505
  11. Rabets JC, Jones JS, Patel A, et al. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population. J Urol. 2004;172:94–97
  12. Bill-Axelson A, Holmberg L, Norlén B, et al. No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examination. J Urol. 2003;170:1180–1183
  13. Morote J, Lopez M, Encabo G, et al. Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol. 2000;37:537–540
  14. Schatteman PH, Hoekx L, Wyndaele JJ, et al. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol. 2000;37:404–412
  15. Akhavan A, Keith JD, Bastacky SI, et al. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. BJU Int. 2007;99:765–769
  16. Langer JE, Rovner ES, Coleman BG, et al. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996;155:228–231
  17. Naya Y, Ayala AG, Tamboli P, et al. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?. Urology. 2004;63:503–508
  18. Moore CK, Karikehalli S, Nazeer T, et al. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol. 2005;173:70–72
  19. San Francisco IF, Olumi AF, Kao J, et al. Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int. 2003;91:350–354
  20. Donzella JG, Merrick GS, Lindert DJ, et al. Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Urology. 2004;63:306–308
  21. Lattouf JB, Grubb RL, Lee SJ, et al. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int. 2007;99:1041–1046
  22. Groskopf J, Aubin SM, Deras IL, et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem. 2006;52:1089–1095

PII: S0090-4295(07)02355-2

doi: 10.1016/j.urology.2007.11.007

Urology
Volume 71, Issue 3 , Pages 399-403 , March 2008

Article Tools